These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 2334455

  • 1. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals.
    Ikeda H, Taketomi S, Sugiyama Y, Shimura Y, Sohda T, Meguro K, Fujita T.
    Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455
    [Abstract] [Full Text] [Related]

  • 2. Effects of pioglitazone on glucose and lipid metabolism in Wistar fatty rats.
    Sugiyama Y, Taketomi S, Shimura Y, Ikeda H, Fujita T.
    Arzneimittelforschung; 1990 Mar; 40(3):263-7. PubMed ID: 2189419
    [Abstract] [Full Text] [Related]

  • 3. Effects of pioglitazone on hepatic and peripheral insulin resistance in Wistar fatty rats.
    Sugiyama Y, Shimura Y, Ikeda H.
    Arzneimittelforschung; 1990 Apr; 40(4):436-40. PubMed ID: 2192715
    [Abstract] [Full Text] [Related]

  • 4. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S.
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [Abstract] [Full Text] [Related]

  • 5. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R, Widdowson PS, Ishii S, Tanaka H, Williams G.
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [Abstract] [Full Text] [Related]

  • 6. Reduction of insulin resistance in obese and/or diabetic animals by 5-[4-(1-methylcyclohexylmethoxy)benzyl]-thiazolidine-2,4-dione (ADD-3878, U-63,287, ciglitazone), a new antidiabetic agent.
    Fujita T, Sugiyama Y, Taketomi S, Sohda T, Kawamatsu Y, Iwatsuka H, Suzuoki Z.
    Diabetes; 1983 Sep; 32(9):804-10. PubMed ID: 6354788
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
    Okuno A, Tamemoto H, Tobe K, Ueki K, Mori Y, Iwamoto K, Umesono K, Akanuma Y, Fujiwara T, Horikoshi H, Yazaki Y, Kadowaki T.
    J Clin Invest; 1998 Mar 15; 101(6):1354-61. PubMed ID: 9502777
    [Abstract] [Full Text] [Related]

  • 8. Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.
    Minoura H, Takeshita S, Yamamoto T, Mabuchi M, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Ita M, Mutoh S.
    Eur J Pharmacol; 2005 Sep 05; 519(1-2):182-90. PubMed ID: 16039648
    [Abstract] [Full Text] [Related]

  • 9. Metabolic recovery of adipose tissue is associated with improvement in insulin resistance in a model of experimental diabetes.
    Takada J, Fonseca-Alaniz MH, de Campos TB, Andreotti S, Campana AB, Okamoto M, Borges-Silva Cd, Machado UF, Lima FB.
    J Endocrinol; 2008 Jul 05; 198(1):51-60. PubMed ID: 18451064
    [Abstract] [Full Text] [Related]

  • 10. Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose-fat diet induced obese rats.
    Ding SY, Shen ZF, Chen YT, Sun SJ, Liu Q, Xie MZ.
    Acta Pharmacol Sin; 2005 May 05; 26(5):575-80. PubMed ID: 15842776
    [Abstract] [Full Text] [Related]

  • 11. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
    Hallakou S, Foufelle F, Doaré L, Kergoat M, Ferré P.
    Diabetologia; 1998 Aug 05; 41(8):963-8. PubMed ID: 9726600
    [Abstract] [Full Text] [Related]

  • 12. Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats.
    Kramer D, Shapiro R, Adler A, Bush E, Rondinone CM.
    Metabolism; 2001 Nov 05; 50(11):1294-300. PubMed ID: 11699047
    [Abstract] [Full Text] [Related]

  • 13. Characterization of new oral antidiabetic agent CS-045. Studies in KK and ob/ob mice and Zucker fatty rats.
    Fujiwara T, Yoshioka S, Yoshioka T, Ushiyama I, Horikoshi H.
    Diabetes; 1988 Nov 05; 37(11):1549-58. PubMed ID: 3053303
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the antidiabetic effects of brain-derived neurotrophic factor and thiazolidinediones in obese diabetic mice.
    Yamanaka M, Itakura Y, Tsuchida A, Nakagawa T, Noguchi H, Taiji M.
    Diabetes Obes Metab; 2007 Nov 05; 9(6):879-88. PubMed ID: 17924870
    [Abstract] [Full Text] [Related]

  • 15. Pioglitazone increases gallbladder volume in insulin-resistant obese mice.
    Al-Azzawi HH, Mathur A, Lu D, Swartz-Basile DA, Nakeeb A, Pitt HA.
    J Surg Res; 2006 Dec 05; 136(2):192-7. PubMed ID: 17045610
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y, DeFronzo RA.
    Diabetes Obes Metab; 2008 Dec 05; 10(12):1204-11. PubMed ID: 18476983
    [Abstract] [Full Text] [Related]

  • 17. Pioglitazone inhibits the diabetogenic action of growth hormone, but not its ability to promote growth.
    Towns R, Kostyo JL, Colca JR.
    Endocrinology; 1994 Feb 05; 134(2):608-13. PubMed ID: 8299559
    [Abstract] [Full Text] [Related]

  • 18. The PPARgamma agonist pioglitazone modifies the vascular sodium-angiotensin II relationship in insulin-resistant rats.
    Zanchi A, Perregaux C, Maillard M, Cefai D, Nussberger J, Burnier M.
    Am J Physiol Endocrinol Metab; 2006 Dec 05; 291(6):E1228-34. PubMed ID: 16835400
    [Abstract] [Full Text] [Related]

  • 19. Enhancement of adipocyte differentiation by an insulin-sensitizing agent.
    Kletzien RF, Clarke SD, Ulrich RG.
    Mol Pharmacol; 1992 Feb 05; 41(2):393-8. PubMed ID: 1538716
    [Abstract] [Full Text] [Related]

  • 20. Influence of the carnitine palmitoyltransferase inhibitor POCA on myocardial performance and metabolism of insulin resistant rats.
    Rösen P, Reinauer H.
    Acta Physiol Hung; 1988 Feb 05; 71(2):271-80. PubMed ID: 3389170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.